A human breast cancer reporter model used to investigate oxidative stress signalling, antioxidant response pathways, and high-throughout compound screening.
| Inventor | Institute |
|---|---|
| Roland Wolf | University of Dundee |
| SKU: | 151014 |
|---|---|
| Product description: | The stable human mammary MCF7 AREc32 reporter cell line contains copies of the rat GST antioxidant response element (ARE) linked to a luciferase reporter gene, such that the induction of the ARE results in luciferase activity. ARE is a transcriptional cis-regulatory element involved in the activation of genes coding for a number of antioxidant proteins and enzymes that work in concert to protect tissues from oxidative insults. This cell line can be used to evaluate how potential anti-cancer agents modulate ARE-mediated antioxidant pathways and identify antioxidant proteins that may serve as potential therapeutic targets. |
| Conditional: | Yes |
| Production details: | The ARE-luciferase reporter plasmid was generated using the pGL3-promoter vector containing an SV40 promoter upstream of the firefly luciferase gene. They differ in the number of copies of ARE sequences that have been inserted, in head-to-tail orientation, through Nhe I & Xho I restrictionsites upstream of the promoter-luc+ transcriptional unit. A plasmid was made containing eight copies of the ARE (5′-GTGACAAAGCA-3′, with the minimal functional sequence underlined) present in both rat GSTA2 and mouse gsta1; called pGL-8xARE. A linker with the sequence of 5′-CCC-3′ and 5′-GGG-3′ on the opposite strand was placed between individual cis-elements.pGL-8xARE, was stably transfected into MCF7 cells using the calcium phosphate method. Transfected cells were selected using 0.8 mg/mL G418 in the media for 3 to 4 weeks. The G418-resistant clones were isolated and screened by measuring their basal and inducible (obtained by treatment with 50 Amol/L t-BHQ) luciferase activities as described above. Positive clones, which showed low background and high inducible luciferase activity, were passaged and maintained in growth medium containing 0.8 mg/mL G418. |
| Cellosaurus ID: | CVCL_1D32 |
| Parental cell line: | MCF7 |
| Disease: | Cancer |
| Cat. #: | 151014 |
|---|---|
| Tool sub type: | Continuous |
| Unit size: | 1×10^6 cells / vial |
| Cancer types: | Breast cancer |
| Organism: | Human |
| Tissue: | Breast |
| Model: | Reporter |
| Primary citation: | Wang et al. 2006. Cancer Res. 66(22):10983-94. PMID: 17108137 |
| Format: | Frozen |
|---|---|
| Storage conditions: | Liquid Nitrogen |
| Shipping conditions: | Dry ice |
| Growth medium: | DMEM with 2.5 mM Glutamax supplemented with 10% fetal bovine serum and antibiotics. Do not culture beyond 15 passages after revival. |
| Subculture routine: | Split sub-confluent cultures (70-80%) 1:3 to 1:6 i.e. seeding at 2-4 x 10^4 cells/cm² using 0.05% trypsin/EDTA solution. Cells are cultured at 37°C, in 95% air and 5% CO₂, and passaged every 3 to 4 days. |
| Recommended controls: | MCF7 parental line |
| Mycoplasma free: | Yes |
| Biosafety level: | 1 |
| References: |
Gameiro et al. 2017. Sci Rep. 7:45701. PMID: 28361919. MacLeod et al. 2016. Br J Cancer. PMID: 27824809. Basar et al. 2016. Phytochem Anal. 27(5):233-8. PMID: 27527356. Braunig et al. 2016. Chemosphere. 156:181-90. PMID: 27176940. Brack et al. 2016. Sci Total Environ. 544:1073-118. PMID: 26779957. Rucker et al. 2015. Org Biomol Chem. 13(10):3040-7. PMID: 25622264. Buendia et al. 2015. Future Med Chem. 7(15):1961-9. PMID: 26496465. Escher et al. 2012. J Environ Monit. 14(11):2877-85. PMID: 23032559. Wang et al. 2007. Proc Natl Acad Sci U S A. 104(49):19589-94. PMID: 18048326. Wang et al. 2006. Cancer Res. 66(22):10983-94. PMID: 17108137. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.